HEALTH● LOWJun 30 · Jun 30, 2026, 5:21 AM
Sanofi's Nexviazyme hits primary goal in Pompe disease study
Seeking Alpha Tech
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH29m agoLost your spark? The "silent sister" of depression, and a quiz to spot herNPR NewsHEALTH58m agoEbola: Africa CDC warns continent ‘not winning’ as cases surpass 10,000Premium TimesHEALTH1h ago‘One in 4 Nigerian stroke patients under 50’Vanguard NigeriaHEALTH1h agoThe national government issued a list of recommendations to prevent and detect a dangerous avian disease after an outbreak in BrazilClarín